Primary |
Drug Use For Unknown Indication |
49.6% |
Insomnia |
17.1% |
Depression |
7.1% |
Product Used For Unknown Indication |
5.9% |
Hypertension |
3.7% |
Drug Exposure During Pregnancy |
2.9% |
Suicide Attempt |
1.5% |
Hyperlipidaemia |
1.4% |
Rheumatoid Arthritis |
1.4% |
Multiple Drug Overdose Intentional |
1.2% |
Intentional Overdose |
1.0% |
Angina Pectoris |
1.0% |
Constipation |
1.0% |
Cardiac Failure Chronic |
0.8% |
Gastritis |
0.8% |
Upper Respiratory Tract Infection |
0.8% |
Cardiac Failure |
0.7% |
Gastric Ulcer |
0.7% |
Osteoporosis |
0.7% |
Anxiety |
0.7% |
|
Delirium |
29.2% |
Road Traffic Accident |
10.1% |
Liver Disorder |
5.4% |
Rhabdomyolysis |
5.4% |
Loss Of Consciousness |
4.7% |
Somnambulism |
4.7% |
Restlessness |
3.9% |
Erythema Multiforme |
3.5% |
Respiratory Depression |
3.5% |
Intentional Overdose |
3.1% |
Suicide Attempt |
3.1% |
Visual Field Defect |
3.1% |
Fracture |
2.7% |
Multiple Drug Overdose Intentional |
2.7% |
Neuroleptic Malignant Syndrome |
2.7% |
Off Label Use |
2.7% |
Overdose |
2.7% |
Death |
2.3% |
Intentional Drug Misuse |
2.3% |
Convulsion |
1.9% |
|
Secondary |
Insomnia |
29.4% |
Drug Use For Unknown Indication |
19.4% |
Depression |
14.0% |
Constipation |
4.8% |
Suicide Attempt |
4.3% |
Hypertension |
4.1% |
Infection |
2.8% |
Gastritis |
2.5% |
Cerebral Infarction |
2.4% |
Convulsion Prophylaxis |
2.3% |
Cardiac Failure Chronic |
2.2% |
Wound Complication |
1.9% |
Major Depression |
1.5% |
Dysthymic Disorder |
1.4% |
Angina Pectoris |
1.4% |
Prophylaxis |
1.3% |
Benign Prostatic Hyperplasia |
1.2% |
Anxiety |
1.1% |
Overdose |
1.1% |
Pyrexia |
1.0% |
|
Suicide Attempt |
16.5% |
Hepatitis Fulminant |
11.5% |
Stevens-johnson Syndrome |
8.2% |
Multiple Drug Overdose Intentional |
6.6% |
Rhabdomyolysis |
5.8% |
Ventricular Tachycardia |
5.8% |
Sepsis |
4.9% |
Pyrexia |
4.1% |
Delirium |
3.7% |
Drug Toxicity |
3.7% |
Erythema Multiforme |
3.7% |
Sexual Abuse |
3.7% |
Somnolence |
3.7% |
Overdose |
3.3% |
Road Traffic Accident |
3.3% |
Blepharospasm |
2.5% |
Toxic Epidermal Necrolysis |
2.5% |
Vomiting |
2.5% |
Confusional State |
2.1% |
Neuroleptic Malignant Syndrome |
2.1% |
|
Concomitant |
Insomnia |
17.7% |
Prophylaxis |
10.2% |
Product Used For Unknown Indication |
9.7% |
Hypertension |
9.6% |
Depression |
7.6% |
Rheumatoid Arthritis |
6.9% |
Drug Use For Unknown Indication |
6.4% |
Constipation |
5.5% |
Chronic Hepatitis C |
5.3% |
Gastritis |
3.1% |
Diabetes Mellitus |
2.5% |
Cancer Pain |
2.4% |
Osteoporosis |
2.0% |
Pain |
1.9% |
Hepatitis C |
1.8% |
Metastatic Renal Cell Carcinoma |
1.7% |
Gastric Ulcer |
1.7% |
Back Pain |
1.4% |
Hyperlipidaemia |
1.4% |
Anxiety |
1.4% |
|
White Blood Cell Count Decreased |
12.7% |
Vomiting |
7.9% |
Interstitial Lung Disease |
6.6% |
Pyrexia |
6.4% |
Rash |
6.2% |
Hepatic Function Abnormal |
5.8% |
Suicide Attempt |
5.8% |
Platelet Count Decreased |
5.5% |
Pneumonia |
4.9% |
Renal Impairment |
4.3% |
Toxic Skin Eruption |
3.8% |
Death |
3.6% |
Liver Disorder |
3.6% |
Loss Of Consciousness |
3.6% |
Renal Failure Acute |
3.6% |
White Blood Cell Count Increased |
3.6% |
Somnolence |
3.1% |
Stomatitis |
3.1% |
Urinary Tract Infection |
2.9% |
Hyponatraemia |
2.8% |
|
Interacting |
Drug Use For Unknown Indication |
51.2% |
Depression |
9.3% |
Neurosis |
9.3% |
Atypical Mycobacterial Infection |
4.7% |
Product Used For Unknown Indication |
4.7% |
Aspergillosis |
2.3% |
Bronchitis Chronic |
2.3% |
Insomnia |
2.3% |
Lung Infection |
2.3% |
Neuropathy Peripheral |
2.3% |
Pneumocystis Jiroveci Infection |
2.3% |
Pneumonia |
2.3% |
Reflux Oesophagitis |
2.3% |
Sleep Disorder Therapy |
2.3% |
|
Drug Toxicity |
25.0% |
Tremor |
25.0% |
Drug Interaction |
12.5% |
Respiratory Depression |
12.5% |
Somnolence |
12.5% |
Vacuum Extractor Delivery |
12.5% |
|